Correlation Between Procter Gamble and Lixte Biotechnology
Can any of the company-specific risk be diversified away by investing in both Procter Gamble and Lixte Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and Lixte Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procter Gamble and Lixte Biotechnology Holdings, you can compare the effects of market volatilities on Procter Gamble and Lixte Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of Lixte Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and Lixte Biotechnology.
Diversification Opportunities for Procter Gamble and Lixte Biotechnology
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Procter and Lixte is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and Lixte Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lixte Biotechnology and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with Lixte Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lixte Biotechnology has no effect on the direction of Procter Gamble i.e., Procter Gamble and Lixte Biotechnology go up and down completely randomly.
Pair Corralation between Procter Gamble and Lixte Biotechnology
Allowing for the 90-day total investment horizon Procter Gamble is expected to under-perform the Lixte Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, Procter Gamble is 9.55 times less risky than Lixte Biotechnology. The stock trades about -0.08 of its potential returns per unit of risk. The Lixte Biotechnology Holdings is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 181.00 in Lixte Biotechnology Holdings on October 24, 2024 and sell it today you would earn a total of 52.00 from holding Lixte Biotechnology Holdings or generate 28.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Procter Gamble vs. Lixte Biotechnology Holdings
Performance |
| Timeline |
| Procter Gamble |
| Lixte Biotechnology |
Procter Gamble and Lixte Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Procter Gamble and Lixte Biotechnology
The main advantage of trading using opposite Procter Gamble and Lixte Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, Lixte Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lixte Biotechnology will offset losses from the drop in Lixte Biotechnology's long position.| Procter Gamble vs. The Clorox | Procter Gamble vs. Colgate Palmolive | Procter Gamble vs. Unilever PLC ADR | Procter Gamble vs. Church Dwight |
| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |